Innovative Imaging and Cognitive BIOmarkers to Predict Huntington's Disease Progression
Recruiting
N/A
Interventional Study
Huntington Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 80 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Intro Huntington's disease (HD) patients suffer from motor, cognitive and behavioral impairments, with heterogeneous phenotypes and variable time course. This leads to a high variance of HD markers, none of which is currently sensitive enough to 1) measure disease progression from small cohort data, 2) predict disease entry in carriers of the HD mutation (during the prodromal phase or in patients …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* For all participants:
* Age ≥18 years and ≤65 years
* Information and collection of written consent
* Affiliation with a social security plan, beneficiary or beneficiary's right
* Healthy controls
* UHDRS functional score TFC = 13
* Motor UHDRS score TMS \< 6 With no known gen…
Contacts